SciVision Biotech Inc (1786) — Cash Flow-to-Debt Ratio
SciVision Biotech Inc (1786) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of NT$-13.02 Million could theoretically repay 0% of its total liabilities (NT$689.35 Million) in one year. Explore how much of SciVision Biotech Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SciVision Biotech Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for SciVision Biotech Inc across 17 annual periods. Also explore SciVision Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for SciVision Biotech Inc (2009–2025)
Year-by-year debt coverage analysis for SciVision Biotech Inc. For market capitalisation and broader financial context, see SciVision Biotech Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | NT$123.99 Million | NT$689.35 Million | ▼ -69.5% |
| 2024 | 0.59x | NT$269.87 Million | NT$457.43 Million | ▲ +15.7% |
| 2023 | 0.51x | NT$272.01 Million | NT$533.66 Million | ▲ +68.0% |
| 2022 | 0.30x | NT$178.21 Million | NT$587.30 Million | ▲ +150.1% |
| 2021 | 0.12x | NT$98.51 Million | NT$812.06 Million | ▼ -53.3% |
| 2020 | 0.26x | NT$126.47 Million | NT$486.55 Million | ▼ -36.3% |
| 2019 | 0.41x | NT$204.40 Million | NT$501.08 Million | ▲ +125.6% |
| 2018 | 0.18x | NT$111.70 Million | NT$617.70 Million | ▲ +634.2% |
| 2017 | 0.02x | NT$15.98 Million | NT$648.72 Million | ▼ -70.2% |
| 2016 | 0.08x | NT$38.29 Million | NT$462.93 Million | ▼ -79.4% |
| 2015 | 0.40x | NT$49.81 Million | NT$124.16 Million | ▲ +1390.5% |
| 2014 | 0.03x | NT$1.85 Million | NT$68.81 Million | ▼ -96.7% |
| 2013 | 0.82x | NT$37.27 Million | NT$45.23 Million | ▼ -8.3% |
| 2012 | 0.90x | NT$51.52 Million | NT$57.31 Million | ▼ -2.7% |
| 2011 | 0.92x | NT$37.13 Million | NT$40.17 Million | ▲ +1401.7% |
| 2010 | 0.06x | NT$6.85 Million | NT$111.24 Million | ▲ +117.8% |
| 2009 | -0.35x | NT$-36.09 Million | NT$104.31 Million | — |